How effective are interventions for the prevention and/or treatment of herpes simplex virus (HSV) in patients receiving treatment for cancer?
No trials reported on duration of hospital stay, amount of analgesia or patient quality of life. In all included trials, risk of bias is unclear.
Treatment of cancer is increasingly effective, but associated with oral complications, such as mucositis, fungal infections, bacterial infections and viral infections, such as HSV. Oral complications can impact severely on quality of life and may lead to life-threatening systemic infection.